top of page
  • Writer's pictureJohn Q Leonard

An Argument for the In-Licensing Biotech Business Model

Here is a concise article that was published recently in the BioEntrepreneur blog that makes a convincing argument in our opinion for pursuing an in-licensing business model approach to starting a pharmaceutical company. Note the figures, the inflection points in the valuation curve and the required investment to reach each milestone or potential exit point for investors.

19 views0 comments

Recent Posts

See All
bottom of page